{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:00Z","timestamp":1761561720317},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T00:00:00Z","timestamp":1358294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-22","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T15:14:33Z","timestamp":1358349273000},"source":"Crossref","is-referenced-by-count":44,"title":["Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma"],"prefix":"10.1186","volume":"13","author":[{"given":"Rea","family":"Federico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Favaretto","family":"Adolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marulli","family":"Giuseppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spaggiari","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DePas Tommaso","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceribelli","family":"Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paccagnella","family":"Adriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crivellari","family":"Gino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russo","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceccarelli","family":"Matteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazeem","family":"Gbenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marchi","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Facciolo","family":"Francesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,16]]},"reference":[{"key":"4143_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA: Advances in malignant mesothelioma. New Engl J Med. 2005, 353: 1591-603. 10.1056\/NEJMra050152.","journal-title":"New Engl J Med"},{"key":"4143_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/14728210903074563","volume":"14","author":"C Belli","year":"2009","unstructured":"Belli C, Fennell D, Giovannini M, Gaudino G, Mutti L: Malignant pleural mesothelioma: current treatments and emerging drugs. Expert Opin Emerg Drugs. 2009, 14: 423-437. 10.1517\/14728210903074563.","journal-title":"Expert Opin Emerg Drugs"},{"key":"4143_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.semtcvs.2009.07.004","volume":"21","author":"W Weder","year":"2009","unstructured":"Weder W, Opitz I, Stahel R: Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009, 21: 172-176. 10.1053\/j.semtcvs.2009.07.004.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"4143_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1586\/era.09.2","volume":"9","author":"PA Zucali","year":"2009","unstructured":"Zucali PA, De Vincenzo F, Simonelli M, Santoro A: Future developments in the management of malignant pleural mesothelioma. Expert Rev Anticancer Ther. 2009, 9: 453-467. 10.1586\/era.09.2.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4143_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, et al: Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011, 12: 763-772. 10.1016\/S1470-2045(11)70149-8.","journal-title":"Lancet Oncol"},{"key":"4143_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0039-6109(02)00033-6","volume":"82","author":"S Singhal","year":"2002","unstructured":"Singhal S, Kaiser LR: Malignant mesothelioma: options for management. Surg Clin North Am. 2002, 82: 797-831. 10.1016\/S0039-6109(02)00033-6.","journal-title":"Surg Clin North Am"},{"issue":"Suppl 5","key":"4143_CR7","doi-asserted-by":"publisher","first-page":"v103","DOI":"10.1093\/annonc\/mdj962","volume":"17","author":"M Marangolo","year":"2006","unstructured":"Marangolo M, Vertogen B: Pemetrexed and malignant pleural mesothelioma. Ann Oncol. 2006, 17 (Suppl 5): v103-105.","journal-title":"Ann Oncol"},{"key":"4143_CR8","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven J, Symanowski J, et al: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003, 21: 2636-2644. 10.1200\/JCO.2003.11.136.","journal-title":"J Clin Oncol"},{"key":"4143_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.06.037","volume":"75","author":"MF McAleer","year":"2009","unstructured":"McAleer MF, Tsao AS, Liao Z: Radiotherapy in malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2009, 75: 326-337. 10.1016\/j.ijrobp.2009.06.037.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4143_CR10","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"LM Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, et al: Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009, 27: 3007-3013. 10.1200\/JCO.2008.20.3943.","journal-title":"J Clin Oncol"},{"key":"4143_CR11","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","volume":"18","author":"W Weder","year":"2007","unstructured":"Weder W, Stahel RA, Bernhard J, for the Swiss Group for Clinical Cancer Research, et al: Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol. 2007, 18: 1196-1202. 10.1093\/annonc\/mdm093.","journal-title":"Ann Oncol"},{"key":"4143_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1183\/09031936.00039510","volume":"36","author":"PE Van Schil","year":"2010","unstructured":"Van Schil PE, Baas P, Gaafar R, et al: Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J. 2010, 36: 1362-1369. 10.1183\/09031936.00039510.","journal-title":"Eur Respir J"},{"issue":"12","key":"4143_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","volume":"12","author":"W Weder","year":"2011","unstructured":"Weder W, Stahel RA, Baas P, et al: The MARS feasibility trial: conclusions not supported by data. Lancet Oncol. 2011, 12 (12): 1093-1094.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:49:50Z","timestamp":1468352990000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,16]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4143"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-22","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,16]]},"article-number":"22"}}